Quiz

Quiz

QUIZ Quiz Chris Callaghan MRCS MRCS(Ed) is an SpR in General Surgery on the East Anglian Rotation in the UK. J Andrew Bradley MBChB FRCS PhD FMedSci...

534KB Sizes 0 Downloads 161 Views

QUIZ

Quiz

Chris Callaghan MRCS MRCS(Ed) is an SpR in General Surgery on the East Anglian Rotation in the UK. J Andrew Bradley MBChB FRCS PhD FMedSci is Professor of Surgery and Director of Transplantation, Addenbrooke’s Hospital, Cambridge, UK.

retroperitoneal dissection, though some surgical units in the UK use a transperitoneal approach. Laparoscopic nephrectomy can be transperitoneal or retroperitoneal. The left kidney is usually taken because of its long renal vein, which makes the recipient operation technically easier. A donor kidney is shown in Figure 2.

Mr TY is 50 years old with end-stage renal failure due to polycystic kidney disease; he requires haemodialysis. His wife, who is ABO blood group compatible, has offered to donate a kidney, and her kidney is transplanted into his right iliac fossa. Both donor and recipient have an uneventful recovery. On discharge from hospital, his serum creatinine concentra­ tion is 145 μmol/l.

On routine transplant clinic follow-up, his serum creatinine concentration was stable at 145–155 μmol/l. However, today, in clinic 2 months post-transplant, his serum creatinine level is 260 μmol/l. He has been admitted to the transplant ward for investigation. He is feeling generally well, though he has felt ‘a bit hot’ recently and has mild diarrhoea. Current immuno­ suppressive medication includes tacrolimus, azathioprine and prednisolone.

Q H  ow is polycystic kidney disease inherited, and which other diseases are associated with it? A T  here are two modes of inheritance: autosomal dominant and ­autosomal recessive. The dominant form is more ­common, ­presents in middle age (Figure 1) and is most often due to a mutation in the PKD1 gene on chromosome 16. It also causes liver cysts and is ­associated with ­intracranial aneurysms, aortic root dilation and cardiac ­murmurs. Autosomal recessive polycystic kidney disease presents in infancy or, if severe, with pulmonary hypoplasia and oligo­ hydramnios at birth. This recessive form of the disease is also associated with hepatic cysts.

Q G  ive a differential diagnosis for his deterioration in renal ­function 2 months post-transplant.

A D  onor nephrectomy can be open or laparoscopic. The open operation is usually undertaken through a flank incision with

A • a cute rejection (which can be associated with systemic symptoms) • opportunistic infection, e.g. infection of the urinary tract, pneumonia, cytomegalovirus gastroenteritis • tacrolimus toxicity • ureteric obstruction and infection of the urinary tract • arterial/venous thrombosis is very unlikely at 2 months post- transplant

Figure 1 Polycystic kidney removed from a patient with the autosomal dominant form of the disease.

Figure 2 The donor kidney is being flushed with cold preservation fluid via a single renal artery. The ureter is draped over the hilum, and the renal vein is obscured.

Q W  hat are the surgical techniques for performing living-donor nephrectomy? If both kidneys have single vessels, which is ­usually taken for transplantation and why?

THE FOUNDATION YEARS 3:2

97

© 2007 Published by Elsevier Ltd.

QUIZ

Q Which  first-line investigations are required and why? Which ­invasive investigation(s) should be performed if the first-line tests are non-diagnostic? A T  he following first-line investigations should be performed: • Full blood cell count azathioprine can cause lymphopenia neutrophilia is associated with infection lymphocytosis is associated with viral infections • Urea and electrolytes check for any further deterioration in renal function; if very severe, venous access and haemodialysis may be needed • Concentration of tacrolimus in blood • Monitoring of cytomegalovirus by polymerase chain reaction of whole blood • Renal transplant ultrasound scan to assess arterial and venous patency and exclude obstruction in the transplant ureter arising from extrinsic compression (e.g. by a hydrocele around the graft caused by lymphatic disruption during transplant surgery) • Mid-stream urine and dipstick • Blood cultures, faecal cultures • Chest radiograph If no cause for reduced renal transplant function is found using the above investigations, a renal transplant biopsy is required. ­Consider rigid sigmoidoscopy and bowel biopsy to look for a ­histological diagnosis of cytomegalovirus.

Figure 3 Courtesy of Dr S Thiru, Consultant Histopathologist, Addenbrooke’s Hospital, Cambridge, UK.

If the episode of acute rejection does not respond to cortico­ steroids, possible treatments include anti-thymocyte globulin or anti-CD-3 monoclonal antibody. Both are associated with signifi­ cant risks of anaphylaxis and fatal pulmonary ­oedema secondary to cytokine release and increased vascular ­permeability.

Figure 3 is a histopathology slide from a renal transplant biopsy. Q What does the slide show?

Further reading Callaghan CJ, Bradley JA. Current status of renal transplantation. Methods Mol Biol 2006; 33: 1–28. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Eng J Med 2004; 351(26): 2715–29. Harris PC, Rosetti S. Molecular genetics of autosomal recessive polycystic kidney disease. Mol Genet Metab 2004; 81: 75–85. Ko DSC, Cosimi AB. The donor and donor nephrectomy. In: Morris PJ, ed. Kidney transplantation, 5th edn. Philadelphia: WB Saunders; 2001. Morrissey PE, Mohaco AP. Living kidney donation: evolution and technical aspects of donor nephrectomy. Surg Clin North Am 2006; 86: 1219–35. Ong AC, Wheatley DN. Polycystic kidney disease—the ciliary connection. Lancet 2003; 361: 774–76. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713–23.

A T  he slide shows acute cellular rejection, with a ­pleomorphic interstitial infiltrate of mononuclear cells (T cells and ­macrophages) and occasional eosinophils, accompanied by interstitial oedema. Foci of tubulitis (lymphocytes infiltrating tubular epithelial cells) are also present (see asterisk on the slide). Acute cellular rejection is mediated by T cells ­responding to foreign major histocompatibility complex or minor ­histocompatibility antigens. Acute cellular rejection is more common than antibody-associated rejection. Q H  ow would you treat this case? What treatment would you use if your first-line medications did not lead to an improvement in renal function? A F  irst-line treatment for acute rejection is high-dose ­corticosteroids given intravenously, e.g. 1 gm methylpredniso­ lone i.v. o.d. for 3 days.

THE FOUNDATION YEARS 3:2

98

© 2007 Published by Elsevier Ltd.